Biosimilars Market
Biosimilars Market
The global biosimilar market size is estimated to grow from USD 34.75 billion in 2024 at 17.6% CAGR (2025 to 2034) to reach an estimated USD 175.79 billion by 2034, as a result of the rising prevalence of cancer, and cost effectivity of biosimilars.
Report ID: 10039
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 34.75 Bn
Forecast Year,
USD USD 175.79 Bn
CAGR, 2025 -
17.6
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Biosimilars Market Size Analysis
Biosimilars Market Size By Product 2024 to 2034 (USD )
| Product | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Recombinant Non-Glycosylated Proteins | 19.11 | 22.39 | 26.62 | 30.75 | 37.09 | 42.21 | 51.66 | 57.94 | 71.95 | 79.53 | 100.21 |
| Recombinant Glycosylated Proteins | 15.64 | 18.47 | 21.43 | 25.77 | 29.38 | 35.95 | 40.26 | 50.16 | 55.17 | 69.96 | 75.60 |
Biosimilars Market Size By Application 2024 to 2034 (USD )
| Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Chronic & Autoimmune Disorders | 9.73 | 11.41 | 13.54 | 15.68 | 18.83 | 21.56 | 26.20 | 29.64 | 36.44 | 40.74 | 50.69 |
| Oncology | 8.69 | 10.25 | 11.93 | 14.27 | 16.39 | 19.87 | 22.52 | 27.65 | 30.93 | 38.49 | 42.49 |
| Blood Disorders | 5.21 | 6.10 | 7.29 | 8.34 | 10.19 | 11.40 | 14.25 | 15.58 | 19.92 | 21.30 | 27.84 |
| Growth Hormonal Deficiency | 3.48 | 4.12 | 4.73 | 5.79 | 6.42 | 8.14 | 8.73 | 11.44 | 11.86 | 16.07 | 16.12 |
| Rheumatoid Arthritis | 4.17 | 4.87 | 5.85 | 6.64 | 8.20 | 9.05 | 11.49 | 12.34 | 16.10 | 16.82 | 22.56 |
| Others | 3.48 | 4.12 | 4.73 | 5.79 | 6.42 | 8.14 | 8.73 | 11.44 | 11.86 | 16.07 | 16.12 |
Biosimilars Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 12.16 | 14.29 | 16.86 | 19.71 | 23.37 | 27.20 | 32.39 | 37.54 | 44.89 | 51.79 | 62.21 |
| Europe | 11.12 | 13.11 | 15.30 | 18.22 | 21.06 | 25.32 | 28.98 | 35.19 | 39.88 | 48.91 | 54.87 |
| Asia-Pacific | 7.65 | 8.97 | 10.62 | 12.35 | 14.75 | 17.01 | 20.48 | 23.43 | 28.44 | 32.26 | 39.49 |
| Latin America | 2.09 | 2.48 | 2.82 | 3.50 | 3.82 | 4.94 | 5.17 | 6.97 | 6.98 | 9.83 | 9.44 |
| Middle East & Africa | 1.74 | 2.02 | 2.46 | 2.73 | 3.47 | 3.68 | 4.91 | 4.97 | 6.93 | 6.70 | 9.79 |
Biosimilars Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
